Hexaminolevulinate (HAL) [clinicaltrials_resource:898243dba73aba2c21706aaee876702e]
intervention [clinicaltrials_vocabulary:intervention]
Hexaminolevulinate (HAL) [clinicaltrials_resource:898243dba73aba2c21706aaee876702e]
Bio2RDF identifier
898243dba73aba2c21706aaee876702e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:898243dba73aba2c21706aaee876702e
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Drug: hexaminolevulinate (HAL) Ointment HAL 100 mg for 5 hours application
intervention name [clinicaltrials_vocabulary:intervention-name]
Hexaminolevulinate (HAL)
identifier
clinicaltrials_resource:898243dba73aba2c21706aaee876702e
title
Hexaminolevulinate (HAL)
@en
type
label
Hexaminolevulinate (HAL) [clinicaltrials_resource:898243dba73aba2c21706aaee876702e]
@en